Moderna to collaborate with AbCellera by Lucy Parsons | Sep 16, 2021 | News | 0 Partnership aims to develop mRNA-encoded antibody therapeutics Read More
Gilead, AbCellera team up against infectious diseases by Anna Smith | Jun 13, 2019 | News | 0 AbCellera will receive upfront and research payments and is eligible to receive downstream clinical and commercial milestone payments and royalties. Read More
AbCellera collaborates with Novartis for antibody discovery by Anna Smith | Feb 14, 2019 | News | 0 AbCellera has announced a multi-target, multi-year deal with Novartis, to identify antibodies for ten therapeutic targets in Novartis’ pipeline, using a unique combination of microfluidics, high-throughput imaging, genomics, deep computing and AI. Read More